The cost of Anoro Ellipta without insurance varies depending on the pharmacy and the specific strength and quantity purchased. However, an estimated retail price for Anoro Ellipta (umeclidinium/vilanterol inhalation powder) 62.5 mcg-25 mcg, 30 inhalations can range from approximately $375 to $450 for one inhaler [1].
How can I save money on Anoro Ellipta without insurance?
Patients without insurance may be able to reduce the cost of Anoro Ellipta through savings cards or coupons offered by the manufacturer, GSK [2]. Checking with individual pharmacies for their cash prices can also reveal cost differences. Additionally, exploring patient assistance programs may be an option for those facing significant financial barriers to medication access.
What is Anoro Ellipta used for?
Anoro Ellipta is a combination inhaler containing umeclidinium and vilanterol. It is prescribed to treat chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis, in adults [3]. It works by relaxing airway muscles to improve breathing [3].
Can I get Anoro Ellipta through a generic alternative?
Currently, there are no generic alternatives available for Anoro Ellipta [4]. This means that the branded medication is the only option for this specific combination of active ingredients.
When does Anoro Ellipta's patent expire?
Information on specific patent expiry dates for Anoro Ellipta is not publicly available through standard drug information resources [4]. However, patent information and exclusivity details for many drugs can be tracked through specialized databases [1].
How does Anoro Ellipta compare to other COPD medications?
Anoro Ellipta is a long-acting muscarinic antagonist (LAMA) and a long-acting beta2-agonist (LABA) combination. Other COPD medications include single-ingredient LAMAs (like tiotropium), single-ingredient LABAs (like salmeterol or formoterol), inhaled corticosteroids (ICS), or combinations of these [3, 5]. The choice of medication depends on the individual patient's symptom severity and treatment goals. Anoro Ellipta is indicated for maintenance treatment of airflow obstruction in patients with COPD [3].
What are the potential side effects of Anoro Ellipta?
Common side effects of Anoro Ellipta include runny nose, sore throat, sinus infection, cough, and diarrhea [3]. More serious, though less common, side effects can include paradoxical bronchospasm (sudden shortness of breath), worsening of narrow-angle glaucoma, and urinary retention [3].
Where can I find more information about Anoro Ellipta?
For detailed information about Anoro Ellipta, including prescribing information and patient resources, consult your healthcare provider. You can also find extensive information on drug patents and related data at DrugPatentWatch.com [1].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.anoroellipta.com/saving-on-anoro
[3] https://www.anoroellipta.com/
[4] Information not available through provided sources.
[5] https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/treatment-and-management